Quidel | QDEL - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 4.27B 669M 2026-09
Agilent USD 475M 10M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Bruker USD 238.9M 3.2M 2026-06
Cerus USD 19.33M 1.55M 2024-12
Charles River Laboratories USD 228.9M 69.47M 2026-06
Danaher USD 2.16B 87M 2026-09
Haemonetics USD 118.94M 1.99M 2026-06
Illumina USD 273M 1000K 2026-06
IQVIA Holdings USD 574M 72M 2026-06
Merit Medical Systems USD 129.23M 18.76M 2026-06
Mettler Toledo International USD 263.33M 5.01M 2026-06
Myriad Genetics USD 122.3M 6.7M 2025-12
Neogen USD 100.8M 1000K 2026-06
OraSure Technologies USD 13.21M 3.29M 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Quidel USD 189.7M 9.6M 2026-06
Revvity USD 278.58M 24.69M 2026-06
STAAR Surgical USD 45.14M 6.5M 2026-06
Thermo Fisher Scientific USD 1.86B 46M 2026-09
Waters USD 405M 11M 2026-06